These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7115932)

  • 1. [Modelling of acute liver failure in rabbits].
    Farber NA; Ketiladze ES; Gubskiĭ LV; Erokhina LG; Braginskiĭ DM
    Biull Eksp Biol Med; 1982 Jun; 93(6):41-5. PubMed ID: 7115932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alterations in hepatic high-energy metabolism in galactosamine-induced acute hepatic failure in rabbits].
    Uchida K
    Nihon Geka Hokan; 1984 Jul; 53(4):580-93. PubMed ID: 6534298
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.
    Sommer BG; Sutherland DE; Matas AJ; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):578-84. PubMed ID: 377697
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.
    Müller-Berghaus G; Reuter C; Bleyl U
    Am J Pathol; 1976 Feb; 82(2):393-406. PubMed ID: 1251892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid in a rabbit model of fulminant hepatic failure.
    Ferenci P; Covell D; Schafer DF; Waggoner JG; Shrager R; Jones EA
    Hepatology; 1983; 3(4):507-12. PubMed ID: 6862362
    [No Abstract]   [Full Text] [Related]  

  • 6. An animal model of fulminant hepatic failure in the rat.
    Watanabe A; Higashi T; Nagashima H
    Acta Med Okayama; 1979 Dec; 33(6):443-50. PubMed ID: 161469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary observations on D-galactosamine-induced hepatic failure in rat models (author's transl)].
    Niu Z
    Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):350-3. PubMed ID: 6796235
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoprotein abnormalities in galactosamine hepatitis: a model of experimental lecithin:cholesterol acyltransferase deficiency.
    Sabesin SM; Kuiken LB; Ragland JB
    Scand J Clin Lab Invest Suppl; 1978; 150():187-93. PubMed ID: 746347
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1.
    Makowka L; Rotstein LE; Falk RE; Falk JA; Zuk R; Langer B; Blendis LM; Phillips MJ
    Can J Surg; 1981 Jan; 24(1):39-44. PubMed ID: 7006772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased blood-brain transfer in a rabbit model of acute liver failure.
    Horowitz ME; Schafer DF; Molnar P; Jones EA; Blasberg RG; Patlak CS; Waggoner J; Fenstermacher JD
    Gastroenterology; 1983 May; 84(5 Pt 1):1003-11. PubMed ID: 6832551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of liver disease.
    Doniach D; Walker G
    Prog Liver Dis; 1972; 4():381-402. PubMed ID: 4569005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute hepatic insufficiency in guinea pigs. Experimental model caused by the injection of monoethanolamine oleate].
    de Macedo AR; Bacchi CE; Spadella CT; Montenegro MR; de Almeida MR; Hossne WS
    Arq Gastroenterol; 1983; 20(3):92-102. PubMed ID: 6677256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tyrosine aminotransferase in galactosamine hepatitis.
    Pugge HR; Torrecilla A; Pellanda RJ
    Acta Gastroenterol Latinoam; 1979; 9(3):159-63. PubMed ID: 43646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early, reversible plasma membrane injury in galactosamine-induced liver cell death.
    El-Mofty SK; Scrutton MC; Serroni A; Nicolini C; Farber JL
    Am J Pathol; 1975 Jun; 79(3):579-96. PubMed ID: 1137005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation and some parameters that affect the galactosamine model of hepatitis in the rat.
    Pickering RW; James GW; Parker FL
    Arzneimittelforschung; 1975 Jun; 25(6):898-901. PubMed ID: 1174326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and clinical relevance of elevated levels of circulating asialoglycoproteins.
    Sawamura T; Shiozaki Y
    Targeted Diagn Ther; 1991; 4():215-34. PubMed ID: 1797157
    [No Abstract]   [Full Text] [Related]  

  • 19. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure].
    Jones EA; Ferenci P; Pappas SC; Schafer DF
    Leber Magen Darm; 1984 Nov; 14(6):282-7. PubMed ID: 6151107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.